Treatment of Vitamin B12 Deficiency in ESRD Patients

Treatment Protocol

The standard treatment approach for patients with vitamin B12 deficiency and End-Stage Renal Disease (ESRD) is intramuscular vitamin B12 administration at a dose of 1000 mcg monthly, with an initial treatment of 1000 mcg intramuscularly every other day for one week, followed by maintenance therapy of 1000 mcg intramuscularly monthly for life, as recommended by Clinical Nutrition 1, 2
Parenteral supplementation remains the reference standard for ESRD patients with B12 deficiency, according to Clinical Nutrition 1
Oral therapy (1000-2000 mcg daily) may be effective in some cases, but it is less well-studied specifically in the ESRD population, as noted by Clinical Nutrition and Praxis Medical Insights 1, 2

Standard multivitamin supplements for dialysis patients should include adequate B12, but may not be sufficient to correct deficiency once it develops, as stated by the American Journal of Kidney Diseases 3

The kidney guidelines recommend evaluating for vitamin B12 deficiency in patients with ESA resistance or persistent anemia, as stated by the Kidney International Supplements 4, 5, 6, 7, 8
The kidney guidelines also recommend evaluating for B12 deficiency in patients with new-onset or persistent ESA resistance, unexplained anemia despite adequate iron stores, or sudden severe transfusion-dependent anemia, according to the Kidney International Supplements 4, 5, 6, 7, 8

Treatment of B12 deficiency corrects the defective DNA synthesis, allowing normal erythropoiesis to resume, as reported in the American Journal of Kidney Diseases 9